Gossamer Bio, Inc.
GOSS
$3.42
$0.4314.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.71% | 16.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.71% | 16.18% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 15.71% | 16.18% | |||
| SG&A Expenses | 8.19% | 0.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.31% | 7.61% | |||
| Operating Income | -7.41% | -5.31% | |||
| Income Before Tax | -25.99% | -4.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.99% | -4.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.99% | -4.46% | |||
| EBIT | -7.41% | -5.31% | |||
| EBITDA | -7.41% | -5.31% | |||
| EPS Basic | -25.59% | -4.27% | |||
| Normalized Basic EPS | -6.18% | -4.16% | |||
| EPS Diluted | -24.41% | -5.26% | |||
| Normalized Diluted EPS | -6.18% | -4.16% | |||
| Average Basic Shares Outstanding | 0.31% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.31% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||